Volume 45, Issue 3
Pages 164 - 169

Insurance and Access Implications of an Over-the-Counter Switch for a Progestin-Only Pill

Authors' Affiliations

Jennifer McIntosh is visiting researcher at the Department of Pharmacy, Hospital Clínic, Barcelona, Spain. Britt Wahlin is director of development and communications, and Kate Grindlay is senior project manager, both at Ibis Reproductive Health, Cambridge, MA. Myra Batchelder is reproductive health consultant. Daniel Grossman is vice president for research, Ibis Reproductive Health, and assistant clinical professor, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco.

The views expressed in this publication do not necessarily reflect those of the Guttmacher Institute.

Perspectives on Sexual and Reproductive Health

Support Our Work

Your support enables the Guttmacher Institute to advance sexual and reproductive health and rights in the United States and globally through our interrelated program of high-quality research, evidence-based advocacy and strategic communications.